|
Marín F, Roldán V. Biomarkers: GDF-15 and risk stratification in atrial fibrillation. Nat Rev Cardiol. 2015 Jan;12(1):8-9. doi: 10.1038/nrcardio.2014.190. Review. PubMed PMID: 25421166.
AÑO: 2015; IF: 49.421
|
25421166
|
Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke. 2014 Mar;45(3):696-701. doi: 10.1161/STROKEAHA.113.003338. PubMed PMID: 24519407.
AÑO: 2014; IF: 5.761
|
|
Cerezo-Manchado JJ, Roldan V, Rosafalco M, Anton AI, Arroyo AB, Garcia-Barbera N, Martínez AB, Padilla J, Corral J, Vicente V, Gonzalez-Conejero R. Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment. Pharmacogenomics. 2014 May;15(7):987-96. doi: 10.2217/pgs.13.232. PubMed PMID: 24956252.
AÑO: 2014; IF: 3.218
|
|
Gallego P, Roldán V, Marin F, Gálvez J, Valdés M, Vicente V, Lip GY. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014 Nov;127(11):1083-8. doi: 10.1016/j.amjmed.2014.05.023. PubMed PMID: 24858062.
AÑO: 2014; IF: 5.003
|
|
Hernández-Romero D, Lahoz Á, Roldan V, Jover E, Romero-Aniorte AI, Martinez CM, Jara-Rubio R, Arribas JM, Garcia-Alberola A, Cánovas S, Valdés M, Marín F. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery. Europace. 2016 Sep;18(9):1328-34. doi: 10.1093/europace/euv354. Epub 2015 Nov 12. PubMed PMID: 26566941.
AÑO: 2016; IF: 4.53
|